Vumerity

Things Just Got Worse for Biogen
Motley Fool
Tue, 04/26/22 - 10:18 am
Biogen
Aduhelm
Alzheimer's disease
Europe
Vumerity
multiple sclerosis
digital health
NICE backs Biogen’s Vumerity for multiple sclerosis
Pharmaforum
Wed, 04/13/22 - 10:40 am
Biogen
NICE
UK
Relapsing Remitting Multiple Sclerosis
Vumerity
Biogen is running out of safety nets
BioPharma Dive
Thu, 10/22/20 - 10:53 am
Biogen
Vumerity
Tecfidera
Spinraza
aducanumab
Biogen points to COVID-19 for disappointing drug launch
BioPharma Dive
Wed, 07/22/20 - 11:42 pm
Biogen
Vumerity
MS
multiple sclerosis
Will Biogen’s Big Patent Victory Ease Investor Worries About Its Alzheimer’s Drug?
Motley Fool
Tue, 02/11/20 - 10:36 am
Biogen
Mylan
Alzheimer's disease
patents
Tecfidera
MS
multiple sclerosis
Vumerity
Novartis, Merck KGaA and Biogen: Which new MS drug do doctors like best? You might be surprised
Fierce Pharma
Tue, 11/19/19 - 02:41 pm
MS
multiple sclerosis
physicians
Novartis
Mayzent
Merck KGaA
Mavenclad
Biogen
Vumerity
Vumerity’s $88,000 List Price Not What ‘We Had Hoped,’ National MS Society Says
Multiple Sclerosis News Today
Thu, 11/14/19 - 07:35 pm
Biogen
MS
multiple sclerosis
Vumerity
drug pricing
Tecfidera
Biogen, Alkermes win FDA approval of Tecfidera successor — but can they actually sell it?
Endpoints
Wed, 10/30/19 - 10:13 am
Biogen
Alkermes
FDA
multiple sclerosis
MS
Vumerity
The patent play: Biogen gets a PhIII boost for its bit-better take on the blockbuster MS franchise drug Tecfidera
Endpoints
Tue, 07/30/19 - 11:29 am
Biogen
Alkermes
MS
multiple sclerosis
Vumerity
clinical trials
Troubled Biogen shows off its me-better approach to MS on PhIII update — but is it really just a patent play?
Endpoints
Thu, 05/30/19 - 09:42 am
Biogen
MS
multiple sclerosis
Tecfidera
ALKS 8700
Vumerity
Alkermes
Alkermes/Biogen hope for less tummy trouble with new MS pill
Pharmaforum
Tue, 12/18/18 - 10:28 am
Alkermes
Biogen
MS
multiple sclerosis
Vumerity